Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance
Journal of Diabetes · 2025-12 · 17 (12)
DOI: 10.1111/1753-0407.70175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 14.12.2025. Verfasst von Xueting Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital, Mianyang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Dysbiosis, Diabetic Nephropathies, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mianyang Central Hospital, Science and Technology Department of Sichuan Province, Mianyang Science and Technology Bureau.
Abstract (Originalsprache)
Background
Diabetic kidney disease (DKD) is characterized by a sustained pro‐inflammatory response of the immune system, which leads to renal failure progression and related complications. Emerging evidence suggests that gut microbiota dysregulation may be a pathogenic mediator in DKD, while mechanisms remain unclear. This study aimed to identify differences in the gut microbiota of the DKD group and healthy controls (HC).
Methods
Gut microbiota composition was determined using shotgun metagenomic sequencing on fecal samples; serum cytokines were measured via ELISA, immune phenotypes were detected using flow cytometry.
Results
Significant differences in gut microbiota diversity and richness were observed between patients with DKD and HC, with higher abundances of Enterobacteriaceae, Serratia , and Shigella in the DKD group than in the HC group. Additionally, CD3+ (especially CD4+) T cells were significantly higher in the renal tissue of the DKD group than the HC group. Flow cytometry identified significantly higher circulating levels of NKT cells and CD8+ T cells and lymphocyte ratio in HC than in DKD. CD4+ cells, CD4+ TCM cells, CD8+ TCM cells, and the CD4+/CD8+ cell ratio were significantly higher in the DKD group than in the HC group, as were levels of pro‐inflammatory mediators, including IL‐6, TNF‐α, and sCD14, and expression of the gut barrier dysfunction marker ZO‐1.
Conclusions
Gut barrier dysfunction and gut microbiota imbalance may mediate the pro‐inflammatory immune phenotype observed in patients with DKD and thereby contribute to DKD progression. These findings underscore the important role of the microbiota–immune axis in the development of DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital, Mianyang, China.
- North Sichuan Medical College, Nanchong, China.
- Department of Gastroenterology, Mianyang Central Hospital, Mianyang, China.
- The Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Department of Pediatrics, Mianyang Central Hospital, Mianyang, China.
- Department of Nephrology, Mianyang Central Hospital, Mianyang, China.
ORCID-Profile: Huan Liu, Jiali Wang
Förderung
- Mianyang Central Hospital
- Science and Technology Department of Sichuan Province
- Mianyang Science and Technology Bureau
Zitieren
APA
Zheng, X., Luo, X., Zhang, Y., Zou, Z., Yang, J., Liu, H., Lu, Z., Cao, F., Wang, X., Ge, X., Li, X., & Wang, J. (2025). Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance. Journal of Diabetes, 17(12). https://doi.org/10.1111/1753-0407.70175
Vancouver
Zheng X, Luo X, Zhang Y, Zou Z, Yang J, Liu H, et al. Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance. Journal of Diabetes. 2025;17(12). doi:10.1111/1753-0407.70175
BibTeX
@article{Zheng2025,
author = {Zheng, Xueting and Luo, Xiaoyan and Zhang, Yi and Zou, Zhiyan and Yang, Jiayi and Liu, Huan and Lu, Zhou and Cao, Fangfang and Wang, Xilian and Ge, Xinyun and Li, Xiaoan and Wang, Jiali},
title = {Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance},
journal = {Journal of Diabetes},
year = {2025},
volume = {17},
number = {12},
doi = {10.1111/1753-0407.70175}
}
EUVIMED